Tarsadia Capital, LLC - SAGE THERAPEUTICS INC ownership

SAGE THERAPEUTICS INC's ticker is SAGE and the CUSIP is 78667J108. A total of 232 filers reported holding SAGE THERAPEUTICS INC in Q3 2020. The put-call ratio across all filers is 0.62 and the average weighting 0.2%.

Quarter-by-quarter ownership
Tarsadia Capital, LLC ownership history of SAGE THERAPEUTICS INC
ValueSharesWeighting
Q3 2020$306,000
-70.6%
5,000
-80.0%
0.03%
-85.9%
Q2 2020$1,040,00025,0000.18%
Other shareholders
SAGE THERAPEUTICS INC shareholders Q3 2020
NameSharesValueWeighting ↓
Casdin Capital, LLC 312,000$29,886,0005.11%
DAFNA Capital Management LLC 104,306$9,991,0004.97%
Palo Alto Investors LP 850,977$81,515,0004.34%
BB BIOTECH AG 1,375,229$131,733,0004.22%
Eventide Asset Management 936,000$89,659,0003.97%
TRV GP II, LLC 37,362$3,579,0003.56%
KINGDON CAPITAL MANAGEMENT, L.L.C. 146,179$14,002,0002.11%
SUFFOLK CAPITAL MANAGEMENT LLC 111,908$10,720,0002.06%
OAK RIDGE INVESTMENTS LLC 231,483$22,174,0001.60%
Rhenman & Partners Asset Management AB 137,339$13,156,0001.50%
View complete list of SAGE THERAPEUTICS INC shareholders